Abstract
In chronic myeloid leukaemia (CML), treatment with interferon alpha IFN-α results in loss of the Ph′ chromosome in a significant proportion of patients. Most cytogenetic responses occur early at a median of 9 months after initiation of treatment and failure to detect a cytogenetic response within a predetermined period may be a reason for IFN-α withdrawal. We report a patient in whom IFN-α dosage was initially severely limited by bone marrow suppression but in whom continuing treatment led to a first cytogenetic response only after 53 months. Increasing Ph′ negativity over a further 2 years was associated with improving haematological tolerance which permitted IFN-α dose escalation and complete cytogenetic remission was achieved at 7 years after diagnosis. This remission has been sustained and has thus followed the most delayed cytogenetic response to IFN-α so far reported.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Whiteway, A., Reid, C. & Cross, N. An extremely delayed cytogenetic response to interferon-α in a patient with chronic myeloid leukaemia. Leukemia 11, 614–616 (1997). https://doi.org/10.1038/sj.leu.2400622
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400622